Radiographic Number of Positive Pelvic Lymph Nodes as a Prognostic Factor in Cervical Cancer Treated With Definitive Concurrent Chemoradiotherapy or Intensity-Modulated Radiotherapy

被引:20
作者
Wang, Shih-Chang [1 ]
Lin, Li-Ching [1 ]
Kuo, Yu-Ting [2 ]
Lin, Yu-Wei [1 ]
机构
[1] Chi Mei Med Ctr, Dept Radiat Oncol, Tainan, Taiwan
[2] Chi Mei Med Ctr, Dept Med Imaging, Tainan, Taiwan
来源
FRONTIERS IN ONCOLOGY | 2018年 / 8卷
关键词
cervical cancer; positive lymph nodes; radiographic finding; survival; CCRT; IMRT; pelvic lymph node; SQUAMOUS-CELL CARCINOMA; RADICAL HYSTERECTOMY; RADIATION-THERAPY; EARLY-STAGE; DISEASE; IMPACT; PATTERNS; SURVIVAL; OUTCOMES; IB;
D O I
10.3389/fonc.2018.00546
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: This study aims to assess the prognostic significance of radiographic numbers of positive pelvic lymph nodes (PLNs) in patients with cervical cancer treated with definitive concurrent chemoradiotherapy (CCRT) or intensity-modulated radiotherapy (IMRT). Methods: We conducted a retrospective study that included 164 eligible adult patients with cervical cancer who were treated with definitive CCRT or IMRT at our institution from 2009 to 2016. After exclusion of 50 patients, a total of 114 patients whose clinicopathological data and follow-up were finally analyzed. The radiographic numbers of positive PLNs were assessed by pretreatment magnetic resonance imaging (MRI) or computed tomography (CT). The criterion for a positive lymph node was defined as a short-axis diameter >1 cm. Using the Kaplan-Meier method and the Cox proportional hazards regression model, we assessed the overall survival (OS), cancer-specific survival (CSS), distant metastasis-free survival (DMFS), and locoregional relapse-free survival (LRFS). Results: The median follow-up duration was 40 (range: 2-100) months. For patients with 0, 1-2, and >= 3 positive PLNs, the estimated 3-year OS were 85.4% vs. 82.4% vs. 59.7% (p = 0.035), CSS were 90.1% vs. 86.1% vs. 62.9% (p = 0.010), DMFS were 89.4% vs. 91.3% vs. 49.6% (p < 0.001), and LRFS were 77.8% vs. 73.4% vs. 70% (p = 0.690). Per the multivariate Cox regression, positive PLNs >= 3 (HR, 2.51; 95% CI: 1.09-5.80; p = 0.031) and non-squamous cell carcinoma type (HR, 2.82; 95% CI: 1.19-6.69; p = 0.018) were unfavorable factors for the OS. Besides, positive PLNs >= 3 was the independent factor for the CSS (HR, 3.38; 95% CI: 1.32-8.67; p = 0.011) and DMFS (HR, 6.83; 95% CI: 2.62-17.83; p < 0.001). The patients that were treated without intracavitary brachytherapy exhibited inferior LRFS (HR, 13.15; 95% CI: 2.66-65.10; p = 0.002). Conclusions: The radiographic number of positive PLNs (>= 3) is an independent prognostic factor for OS, CSS, and DMFS in patients treated with definitive CCRT or IMRT.
引用
收藏
页数:8
相关论文
共 34 条
[1]  
[Anonymous], J CLIN ONCOL S15
[2]   The prognostic impact of histological type on clinical outcomes of early-stage cervical cancer patients whom have been treated with radical surgery [J].
Chandeying, Nutthaporn ;
Hanprasertpong, Jitti .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2017, 37 (03) :347-354
[3]   Definitive intensity-modulated radiation therapy with concurrent chemotherapy for patients with locally advanced cervical cancer [J].
Chen, Chien-Chih ;
Lin, Jin-Ching ;
Jan, Jian-Sheng ;
Ho, Shih-Chu ;
Wang, Lily .
GYNECOLOGIC ONCOLOGY, 2011, 122 (01) :9-13
[4]  
Chittithaworn S, 2007, ASIAN PAC J CANCER P, V8, P530
[5]   Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer [J].
Cihoric, Nikola ;
Tsikkinis, Alexandros ;
Tapia, Coya ;
Aebersold, Daniel M. ;
Zlobec, Inti ;
Loessl, Kristina .
RADIATION ONCOLOGY, 2015, 10
[6]   Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: A systematic review and meta-analysis [J].
Datta, Niloy Ranjan ;
Stutz, Emanuel ;
Liu, Michael ;
Rogers, Susanne ;
Klingbiel, Dirk ;
Siebenhuner, Alexander ;
Singh, Shalini ;
Bodis, Stephan .
GYNECOLOGIC ONCOLOGY, 2017, 145 (02) :374-385
[7]   PROSPECTIVE SURGICAL PATHOLOGICAL-STUDY OF DISEASE-FREE INTERVAL IN PATIENTS WITH STAGE IB SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].
DELGADO, G ;
BUNDY, B ;
ZAINO, R ;
SEVIN, BU ;
CREASMAN, WT ;
MAJOR, F .
GYNECOLOGIC ONCOLOGY, 1990, 38 (03) :352-357
[8]   Global strategies for the treatment of early-stage and advanced cervical cancer [J].
Duenas-Gonzalez, Alfonso ;
Campbell, Sergio .
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2016, 28 (01) :11-17
[9]   Prognostic factors for patients with cervical cancer treated with concurrent chemoradiotherapy: a retrospective analysis in a Japanese cohort [J].
Endo, Daisuke ;
Todo, Yukiharu ;
Okamoto, Kazuhira ;
Minobe, Shinichiro ;
Kato, Hidenori ;
Nishiyama, Noriaki .
JOURNAL OF GYNECOLOGIC ONCOLOGY, 2015, 26 (01) :12-18
[10]   Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 [J].
Ferlay, Jacques ;
Soerjomataram, Isabelle ;
Dikshit, Rajesh ;
Eser, Sultan ;
Mathers, Colin ;
Rebelo, Marise ;
Parkin, Donald Maxwell ;
Forman, David ;
Bray, Freddie .
INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (05) :E359-E386